PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23111893-0	2013	Intervention of rosiglitazone on myocardium Glut-4 mRNA expression during ischemia-reperfusion injury in cardio-pulmonary bypass in dogs.	Rosiglitazone	16-29	solute carrier family 2 member 4	Canis lupus familiaris	44-50	
23111893-3	2013	This study further examined whether rosiglitazone, a synthetic agonist of peroxisome proliferator-activated receptor gamma, could intervene glucose metabolism by regulating Glut-4 mRNA during I/R in dogs.	Rosiglitazone	36-49	solute carrier family 2 member 4	Canis lupus familiaris	173-179	
23111893-8	2013	On the other hand, these changes were relatively mild in dogs treated with rosiglitazone in cardioplegic solution and expression of Glut-4 mRNA was increased remarkably.	Rosiglitazone	75-88	solute carrier family 2 member 4	Canis lupus familiaris	132-138	
23111893-11	2013	Adding rosiglitazone into the cardioplegic solution during I/R can increase the amount of Glut-4 mRNA expression, mitigate the myocardium insulin resistance and improve the myocardium I/R injury during CPB.	Rosiglitazone	7-20	solute carrier family 2 member 4	Canis lupus familiaris	90-96